API Suppliers
US DMFs Filed
0
CEP/COS Certifications
0
JDMFs Filed
0
Other Certificates
0
Other Suppliers
0
0
USA (Orange Book)
Europe
0
Canada
0
Australia
0
South Africa
0
Uploaded Dossiers
0
U.S. Medicaid
Annual Reports
0
https://recalls-rappels.canada.ca/en/alert-recall/idhifa-enasidenib-mesylate-market-withdrawal-and-continued-access
https://www.fiercepharma.com/marketing/bristol-myers-squibb-s-ex-celgene-aml-drug-idhifa-fails-to-extend-patients-lives
https://www.biopharmadive.com/news/agios-mitapivat-royalty-deal/579749/
https://www.reuters.com/article/us-column-miller-medicare/medicare-part-d-no-match-for-runaway-specialty-drug-costs-study-idUSKCN1PW16X
https://www.fiercepharma.com/pharma/agios-wins-fda-nod-for-targeted-aml-drug-tibsovo
https://endpts.com/agios-scores-its-second-new-drug-approval-ivosidenib-heads-to-the-aml-market/
https://endpts.com/after-some-careful-scrutiny-a-top-analyst-questions-the-high-failure-rate-for-celgenes-drug-pipeline/